Building on its government affairs and public policy department, the National Association of Chain Drug Stores has hired Christopher Smith, formerly with the National Community Pharmacists Association, as director of federal public policy.
Does the Obama administration “get it” when it comes to pharmacy’s vital interests and lowering health care costs?
One sometimes wonders. As much as I like the president and many of his ideas and instincts, I’m sometimes stumped by some of the lesser-understood facets of the administration’s health policy, and by the seemingly contradictory sets of priorities promoted by that policy.
Medicare Part D beneficiaries with cardiovascular conditions who had no financial assistance during the "doughnut hole" coverage gap were 57% more likely to discontinue their cardiovascular medications than those beneficiaries who had consistent drug coverage, according to a study conducted by researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark.
The program to offer certain generic drugs virtually for free to Medicare Part D beneficiaries is one of Rite Aid’s many new ways to attract more customers and thus grow its sales and profits, especially in the pharmacy.
Medicare Part D beneficiaries who enter the "doughnut hole," where they have to pay 100% of previously subsidized prescription costs, are twice as likely to discontinue their medications as they are to switch to more affordable or generic medications, according to a new study conducted by researchers from Harvard University, Brigham and Women's Hospital and CVS Caremark.
The National Community Pharmacists Association on Thursday spoke out against a Florida bill sponsored by state Rep. Rob Schenck, R-District 44, which would restrict the dispensing of controlled substances on Schedule II and III to publicly traded pharmacy chains and pharmacies that have more than $100 million in taxable revenues, or only those independent community pharmacies that have been in business more than 10 years.
Ten states could reap significant savings by increasing the use of generic drugs in their state Medicaid programs, the Generic Pharmaceutical Association said Monday in response to a report by the American Enterprise Institute, a conservative think tank.
With the defeat of Democrat Martha Coakley by Republican Scott Brown in the race to fill the seat of late Massachusetts Sen. Ted Kennedy, and the loss of the Democrats’ filibuster-proof majority in the Senate, the healthcare-reform bill stands on a knife’s edge. And how will pharmacies be reimbursed for dispensing generic drugs to Medicaid and Medicare patients if a health overhaul bill fails to pass? These topics, along with the issue of patent settlements vexing the branded and generic drug industries and a new GAO study showing that drug costs are soaring, are explored in depth in the latest installment of the ECRM Generics report.